208 related articles for article (PubMed ID: 27893188)
21. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
Wang J; Wen T; Li Z; Che X; Gong L; Jiao Z; Qu X; Liu Y
Aging (Albany NY); 2020 Nov; 13(2):1883-1897. PubMed ID: 33232276
[TBL] [Abstract][Full Text] [Related]
22. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
[TBL] [Abstract][Full Text] [Related]
23. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
[TBL] [Abstract][Full Text] [Related]
24. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
Ge W; Chen Y; Guo Y; Zhao D; Mu L; Zhang K; Zhuo W
Biochem Biophys Res Commun; 2021 Sep; 570():117-124. PubMed ID: 34280614
[TBL] [Abstract][Full Text] [Related]
25. DEK: A novel early screening and prognostic marker for breast cancer.
Ying G; Wu Y
Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
[TBL] [Abstract][Full Text] [Related]
26. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.
Kuo YJ; Lewis JS; Zhai C; Chen YA; Chernock RD; Hsieh MS; Lan MY; Lee CK; Weinreb I; Hang JF
Mod Pathol; 2021 Oct; 34(10):1820-1830. PubMed ID: 34108636
[TBL] [Abstract][Full Text] [Related]
27. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.
Cifdaloz M; Osterloh L; Graña O; Riveiro-Falkenbach E; Ximénez-Embún P; Muñoz J; Tejedo C; Calvo TG; Karras P; Olmeda D; Miñana B; Gómez-López G; Cañon E; Eyras E; Guo H; Kappes F; Ortiz-Romero PL; Rodríguez-Peralto JL; Megías D; Valcárcel J; Soengas MS
Nat Commun; 2017 Dec; 8(1):2249. PubMed ID: 29269732
[TBL] [Abstract][Full Text] [Related]
28. DEK modulates both expression and alternative splicing of cancer‑related genes.
Liu B; Sun Y; Zhang Y; Xing Y; Suo J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35475534
[TBL] [Abstract][Full Text] [Related]
29. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates DEK to promote the progression of lung squamous cell carcinoma.
Xie S; Wan X; Chen S; Hu Y; Liu X
Lab Invest; 2022 Oct; 102(10):1109-1120. PubMed ID: 35821094
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer's disease cell model.
Miao J; Jing J; Shao Y; Sun H
BMC Neurosci; 2020 Jul; 21(1):33. PubMed ID: 32736520
[TBL] [Abstract][Full Text] [Related]
31. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
32. In silico gene expression and pathway analysis of DEK in the human brain across the lifespan.
Greene AN; Nguyen ET; Paranjpe A; Lane A; Privette Vinnedge LM; Solomon MB
Eur J Neurosci; 2022 Sep; 56(6):4720-4743. PubMed ID: 35972263
[TBL] [Abstract][Full Text] [Related]
33. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
[TBL] [Abstract][Full Text] [Related]
34. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.
Pierzynska-Mach A; Cainero I; Oneto M; Ferrando-May E; Lanzanò L; Diaspro A
Sci Rep; 2023 Aug; 13(1):12749. PubMed ID: 37550322
[TBL] [Abstract][Full Text] [Related]
35. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
36. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
[TBL] [Abstract][Full Text] [Related]
37. Roles of DEK in the endometrium of mice in early pregnancy.
Yang Y; Wu M; Geng Y; Liu X; Yang Y; Chen X; Ding Y; He J; Wang Y; Xie L
Gene; 2018 Feb; 642():261-267. PubMed ID: 29109007
[TBL] [Abstract][Full Text] [Related]
38. DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.
Çalışkaner ZO; Çakar T; Özçelik E; Özdilek A; Kim AS; Doğan Ö; Bosompem A; Grosveld G; Saka B; Kandilci A
PLoS One; 2017; 12(5):e0178025. PubMed ID: 28558048
[TBL] [Abstract][Full Text] [Related]
39. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
40.
Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]